Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
Spot attribution powers Roku's optimization for better campaign performanceNEW YORK--(BUSINESS WIRE)--Roku, Inc. (NASDAQ: ...
Roku will be the first major streamer to use measurement firm iSpot's Outcomes at Scale metric in a bid to improve targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback